CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teva Branded Pharmaceutical Products R&D Inc. v. Perrigo Pharmaceuticals Co.

1:12-cv-01101

Overview

Case Number 1:12-cv-01101
Filing Date 2012-09-05
Status Terminated
Termination Date 2014-06-20
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Catalent Pharma Solutions LLC NPE (Patent Assertion Entity)

Represented By

2 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Perrigo Company NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

William F. Ward

Email: wward@rmmslegal.com

Brian P. Murray

Email: Brian.Murray@hklaw.com

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Perrigo Pharmaceuticals Co. Operating Company

Represented By

12 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Yixin H. Tang

Email: yixin@ipfdalaw.com

William A. Rakoczy

Email: wrakoczy@rmmslegal.com

Timothy F. Peterson

Email: tim.peterson@bipc.com

Thomas R. Burns , Jr.

Email: Burns@adduci.com

Nicole E. Kopinski

Email: nkopinski@leydig.com

Neil B. McLaughlin

Email: nmclaughlin@rmmslegal.com

Matthew T. Lord

UNDELIVERABLE EMAIL 12/18/13

Joseph T. Jaros

Email: jjaros@rmmslegal.com

Jeffrey A. Marx

Email: jmarx@rmmslegal.com

Deanne M. Mazzochi

Email: dmazzochi@rmmslegal.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Plaintiff

Norton Healthcare Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Stephanie E. O'Byrne

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6067

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Norton (Waterford) Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Stephanie E. O'Byrne

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6067

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Teva Respiratory LLC Operating Company

Represented By

3 Attorneys Listed

Stephanie E. O'Byrne

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6067

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Teva Branded Pharmaceutical Products R&D Inc. Operating Company

Represented By

13 Attorneys Listed

Timothy J. Rousseau

Email: trousseau@brownrudnick.com

Stephanie E. O'Byrne

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6067

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Paul F. Ware

Email: pware@goodwinprocter.com

Nicholas K. Mitrokostas

Email: nicholas.mitrokostas@allenovery.com

Natasha E. Daughtrey

Email: ndaughtrey@goodwinlaw.com

Kevin J. DeJong

Email: kdejong@goodwinlaw.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Ira J. Levy

Email: ilevy@goodwinlaw.com

David M. Hashmall

Email: dhashmall@goodwinlaw.com

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Brian J. Prew

Email: prewb@gtlaw.com

Andrew E. Riley

Email: ariley@goodwinprocter.com

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2017-03-21
1:17-cv-00307

Teva Branded Pharmaceutical Products R&D, Inc. v. Lupin Alantis Holdings SA

U.S. Family Sibling (["US7105152", "US8132712", "US9463289"])
Status: DED
U.S. District Court 2013-08-16
1:13-cv-01441

Teva Branded Pharmaceutical Products R&D Inc. v. Perrigo Pharmaceuticals Co.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7105152
Suspension aerosol formulations
Filed: 1995-05-31
Issued: 2006-09-12
Expired (Term Ended)
Expires: 2015-05-31
US7566445
Medicinal aerosols and methods of delivery thereof
Filed: 1997-06-04
Issued: 2009-07-28
Expired (Term Ended)
Expires: 2017-06-04
US6446627
Inhaler dose counter
Filed: 1997-12-18
Issued: 2002-09-10
Expired (Term Ended)
Expires: 2017-12-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

7

Dispositive

0

Granted

0

Denied

0

Pending / Review

7

Motions by Category

Procedural / Extension Motion 5 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
REPLY BRIEF re 61 MOTION for Leave to File Defendants' Motion to Supplement Their Counterclaims in the Lead Action filed by Catalent Pharma Solutions LLC, Perri...
Entry #76 • 2013-10-10 Document →
Procedural / Extension Motion Pending / Under Review
[SEALED] RESPONSE to Motion re 61 MOTION for Leave to File Defendants' Motion to Supplement Their Counterclaims in the Lead Action filed by Norton (Waterford) L...
Entry #74 • 2013-09-30 Document →
Claim Construction / Markman Filing Pending / Under Review
STIPULATION to Suspend Submission of Opening Claim Construction Briefs by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Phillips...
Entry #62 • 2013-09-16 Document →
Procedural / Extension Motion Pending / Under Review
MOTION for Leave to File Defendants' Motion to Supplement Their Counterclaims in the Lead Action - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perr...
Entry #61 • 2013-09-13 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM Construction Chart by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., ...
Entry #49 • 2013-09-06 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME Time for Plaintiffs and Defendants to substantially complete document production to August 16, 2013 - filed by Catalent Pharma Soluti...
Entry #38 • 2013-07-24 Document →

Docket Entries

(80 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1133533.) - filed by Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc., Norton (Waterford) Limited, Norton Healthcare Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dzb, ) (Entered: 09/06/2012)

Entry #1 • 2012-09-05
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dzb, ) (Entered: 09/06/2012)

Entry #2 • 2012-09-05
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 7/25/12. Date of Expiration of Patent: '152 - 9/12/23; '445 - 6/4/17.Thirty Month Stay Deadline: 1/25/2015. (dzb, ) (Entered: 09/06/2012)

Entry #3 • 2012-09-05
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,105,152; 7,566,445;. (dzb, ) Modified on 9/6/2012 (dzb, ). (Entered: 09/06/2012)

Entry #4 • 2012-09-05
1

Disclosure Statement pursuant to Rule 7.1 filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC identifying Corporate Parent Teva Pharmaceutical Industries Limited for Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (dzb, ) (Entered: 09/06/2012)

Entry #5 • 2012-09-05
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc